Johnson Johnson Aktie
150,26
EUR
+1,10
EUR
+0,74
%
176,69
USD
+0,05
USD
+0,03
%
nachbörslich
Johnson Johnson jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Kursziele der Johnson Johnson-Aktie in
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Allergan Inc. | 0 | 0 | 0 | - | - |
| APONTIS PHARMA | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 5 | 3 | 0 | 138,72 GBP | +23,75% |
| Bayer | 2 | 7 | 0 | 26,88 EUR | -2,75% |
| Beiersdorf AG | 7 | 3 | 1 | 123,50 EUR | +39,45% |
| BioNTech (ADRs) | 4 | 2 | 0 | 135,33 USD | +35,67% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| Celgene Corp. | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| Douglas AG | 3 | 1 | 0 | - | - |
| Fresenius Medical Care (FMC) St. | 3 | 4 | 3 | 47,89 EUR | +8,52% |
| Fresenius SE & Co. KGaA (St.) | 8 | 2 | 0 | 50,81 EUR | +8,61% |
| GSK PLC Registered Shs | 1 | 6 | 1 | 16,04 GBP | +8,01% |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 6 | 2 | 0 | 148,71 EUR | +37,38% |
| Moderna Inc | 0 | 1 | 0 | 42,00 USD | +62,29% |
| MorphoSys | 0 | 0 | 0 | - | - |
| Nestlé SA (Nestle) | 3 | 8 | 0 | 82,31 CHF | +15,47% |
| Novartis AG | 3 | 4 | 2 | 98,25 CHF | +0,43% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 4 | 0 | 29,17 USD | +21,09% |
| Procter & Gamble Co. | 1 | 0 | 0 | 177,00 USD | +16,13% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 8 | 1 | 0 | 111,00 EUR | +39,99% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Unilever plc | 6 | 1 | 3 | 50,05 GBP | +12,32% |
| Valneva | 0 | 0 | 0 | - | - |